Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Paid-in Capital
Accumulated Other Comprehensive Income (Loss), net of tax
Retained Earnings (Deficit)
Beginning balance (in shares) at Dec. 25, 2022   20,449        
Beginning balance at Dec. 25, 2022 $ 1,789 $ 20 $ (182,810) $ 238,803 $ (34) $ (54,190)
Beginning balance (in shares) at Dec. 25, 2022     4,515      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (456)      
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan 2,005   $ 18,068 (16,063)    
Acquisition of treasury stock (in shares)     862      
Acquisition of treasury stock (9,960)   $ (9,960)      
Non-cash stock compensation 6,940     6,940    
Net income (loss) (21,228)         (21,228)
Other comprehensive income (loss) 12       12  
Ending balance (in shares) at Dec. 31, 2023   20,449        
Ending balance at Dec. 31, 2023 (20,442) $ 20 $ (174,702) 229,680 (22) (75,418)
Ending balance (in shares) at Dec. 31, 2023     4,921      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (274)      
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (300)   $ 9,765 (10,065)    
Non-cash stock compensation 6,961     6,961    
Net income (loss) (77,541)         (77,541)
Common stock issuance (in shares)   1,601        
Common stock issuance 7,093 $ 2   7,091    
Other comprehensive income (loss) $ (40)       (40)  
Ending balance (in shares) at Dec. 29, 2024 17,403 22,050        
Ending balance at Dec. 29, 2024 $ (84,269) $ 22 $ (164,937) 233,667 (62) (152,959)
Ending balance (in shares) at Dec. 29, 2024 4,647   4,647      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan (in shares)     (606)      
Exercise of options, issuance of restricted stock, shares exchanged for exercise and tax, and stock issued through employee stock purchase plan $ 472   $ 21,690 (21,218)    
Non-cash stock compensation 1,210     1,210    
Net income (loss) (23,284)         (23,284)
Equity issuance costs (479)     (479)    
Other comprehensive income (loss) $ 2       2  
Ending balance (in shares) at Dec. 28, 2025 18,009 22,050        
Ending balance at Dec. 28, 2025 $ (106,348) $ 22 $ (143,247) $ 213,180 $ (60) $ (176,243)
Ending balance (in shares) at Dec. 28, 2025 4,041   4,041